In addition, migrating GBM cells showing a stemness-like phenotype are characterized by expressing high levels of CD44 and low levels of programmed cell death protein (PDCD)4, a factor known to inhibit YB-1 expression [54]. The gene discussed is CD44; the disease is glioblastoma.